Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia.
Kumar B, Afshar-Kharghan V, Mendt M, Sackstein R, Tanner MR, Popat U, Ramdial J, Daher M, Jimenez J, Basar R, Melo Garcia L, Shanley M, Kaplan M, Wan X, Nandivada V, Reyes Silva F, Woods V, Gilbert A, Gonzalez-Delgado R, Acharya S, Lin P, Rafei H, Banerjee PP, Shpall EJ.
Kumar B, et al. Among authors: shpall ej.
Front Immunol. 2022 Sep 20;13:1018047. doi: 10.3389/fimmu.2022.1018047. eCollection 2022.
Front Immunol. 2022.
PMID: 36203567
Free PMC article.